A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
Clinical trial NCT05815680 · COMPLETED
Trial details
- NCT number
- NCT05815680
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-06
- Primary completion
- 2023-08-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.